Loading

Please wait...

Blisovi 24 fe

Generic Name: ethinyl estradiol and norethindrone (birth control) (ETH in il ess tra DYE ole and nor ETH in drone)
Brand Name: Blisovi 24 FE, Estrostep Fe, Femcon FE, Kaitlib FE, Lo Minastrin Fe, Microgestin 24 FE, Norinyl 1+35, Ortho-Novum 7/7/7, Taytulla, Tri-Norinyl, Zenchent
Physician reviewed Blisovi 24 FE (birth control) (birth control) patient information - includes Blisovi 24 FE (birth control) description, dosage and directions.

Average Savings for blisovi 24 fe (generic): 17.96%
  • Prescription Settings
  • X

Prices and coupons of Blisovi 24 fe

Set your location
for drug prices near you

Enter your zip code


Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Blisovi 24 FE is a combination birth control pill containing female hormones that prevent ovulation (the release of an egg from an ovary). This medication also causes changes in your cervical mucus and uterine lining, making it harder for sperm to reach the uterus and harder for a fertilized egg to attach to the uterus. Blisovi 24 FE is used as contraception to prevent pregnancy. Blisovi 24 FE is also used to treat moderate acne in women who are at least 15 years old and have started having menstrual periods, and who wish to use birth control pills. There are many available brands of ethinyl Estradiol and norethindrone. Not all brands are listed on this leaflet. Learn more

Blisovi 24 fe Side Effects

Blisovi 24 Fe Side Effects

Note: This document contains side effect information about ethinyl estradiol / norethindrone. Some of the dosage forms listed on this page may not apply to the brand name Blisovi 24 Fe.

For the Consumer

Applies to ethinyl estradiol / norethindrone: oral capsule liquid filled, oral tablet, oral tablet chewable

Other dosage forms:

  • oral tablet, oral tablet chewable

Warning

Oral route (Tablet)

Junel®, Loestrin®, Microgestin®, Tri-Legest®: Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.Femhrt®: Estrogen alone or with a progestin should not be used for the prevention of cardiovascular disease or dementia. Increased risks of stroke, DVT, pulmonary embolism, myocardial infarction, and invasive breast cancer have been reported with estrogen plus progestin therapy. Increased risks of stroke and DVT have been reported with estrogen-alone therapy, along with increased risk for endometrial cancer in a woman with a uterus who uses unopposed estrogens. An increased risk of probable dementia in postmenopausal women aged 65 and older has been reported with estrogen alone and with estrogen plus progestin therapy. Risks should be assumed to be similar for other doses, combinations, and dosage forms of estrogens and progestins. Estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration possible.

Along with its needed effects, ethinyl estradiol/norethindrone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking ethinyl estradiol / norethindrone:

Incidence not known

  • Absent, missed, or irregular menstrual periods
  • anxiety
  • change in vision
  • changes in skin color
  • chest pain or discomfort
  • chills
  • clay-colored stools
  • constipation
  • cough
  • dark urine
  • diarrhea
  • dizziness or lightheadedness
  • fainting
  • fast heartbeat
  • fever
  • headache
  • hives or welts
  • itching skin
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • loss of appetite
  • medium to heavy, irregular vaginal bleeding between regular monthly periods, which may require the use of a pad or a tampon
  • nausea
  • pain or discomfort in the arms, jaw, back, or neck
  • pain, tenderness, or swelling of the foot or leg
  • pains in the chest, groin, or legs, especially in the calves of the legs
  • pounding in the ears
  • rash
  • redness of the skin
  • severe headaches of sudden onset
  • slow or fast heartbeat
  • stomach pain
  • sudden loss of coordination or slurred speech
  • sweating
  • troubled breathing
  • unusual tiredness or weakness
  • vomiting
  • vomiting of blood

Some side effects of ethinyl estradiol / norethindrone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

  • Bloating
  • blotchy spots on the exposed skin
  • breast enlargement or tenderness
  • discouragement
  • feeling sad or empty
  • irritability
  • itching of the vagina or outside genitals
  • loss of interest or pleasure
  • pain during sexual intercourse
  • stomach cramps
  • thick, white curd-like vaginal discharge without odor or with mild odor
  • tiredness
  • trouble concentrating
  • trouble sleeping
  • trouble wearing contact lenses

For Healthcare Professionals

Applies to ethinyl estradiol / norethindrone: oral capsule, oral tablet, oral tablet chewable

General

The most frequently reported side effects were headache, vaginal candidiasis, nausea, menstrual cramps, breast tenderness, abdominal pain, mood changes, bacterial vaginitis, acne, irregular uterine bleeding, and weight gain.

Genitourinary

Common (1% to 10%): Vaginal candidiasis, menstrual cramps, breast tenderness, bacterial vaginitis, abnormal/irregular bleeding, metrorrhagia, irregular menstruation, menorrhagia, vaginal hemorrhage, breast pain, dysmenorrhea, vaginal hemorrhage, dysfunctional uterine bleeding

Frequency not reported: Ovarian vein thrombosis, vaginitis, amenorrhea, breakthrough bleeding, breast enlargement, breast secretion, cervical erosion changed, cervical secretion, menstrual flow changed, diminution in lactation, spotting, temporary infertility after discontinuation of treatment, premenstrual syndrome, uterine fibroid disease exacerbated

Postmarketing reports: Vaginal infection, pollakiuria, dysuria, ovarian cyst, pelvic pain, ovarian cyst rupture, pelvic fluid collection, nipple pain, nipple discharge, galactorrhea, fibrocystic breast change, breast disorder, breast mass, uterine leiomyomata size increased, cervical ectropion changed, endometrial hyperplasia, ovarian cyst, uterine enlargement

Cardiovascular

Uncommon (0.1% to 1%): Blood pressure increased

Frequency not reported: Deep vein thrombosis, myocardial infarction, hypertension, arterial thromboembolism, thrombophlebitis

Postmarketing reports: Coronary artery thrombosis, palpitation, tachycardia, angina pectoris, hot flush, heart rate irregular

Gastrointestinal

Common (1% to 10%): Nausea/vomiting, abdominal pain

Frequency not reported: Abdominal cramps, bloating, colitis, dyspepsia, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mesenteric thrombosis

Postmarketing reports: Constipation, pancreatitis

Nervous system

Common (1% to 10%): Headache

Frequency not reported: Migraine, dizziness, cerebral hemorrhage, cerebral thrombosis

Postmarketing reports: Loss of consciousness, hyperesthesia, paresthesia, hypoesthesia, somnolence, sensory disturbance, transient ischemic attack, ischemic stroke, chorea, epilepsy exacerbated, dementia, hemiparesis

Oncologic

Frequency not reported: Hepatic adenoma, hepatic carcinoma, benign liver tumor

Postmarketing reports: Hemangioma of liver, breast cancer, ovarian cancer, endometrial cancer, uterine cancer

Endocrine

Postmarketing reports: Hypothyroidism, hyperthyroidism

Psychiatric

Common (1% to 10%): Mood swing, depression, mood changed, anxiety

Frequency not reported: Nervousness

Postmarketing reports: Insomnia, suicidal ideation, panic attack, libido changed, homicidal ideation, dissociation, bipolar disorder, mood disturbed, irritability

Dermatologic

Common (1% to 10%): Acne

Frequency not reported: Hirsutism, loss of scalp hair, melasma, chloasma, erythema multiforme, erythema nodosum, hemorrhagic eruption, photosensitivity, pruritus

Postmarketing reports: Alopecia, generalized rash, allergic rash, skin discoloration, urticaria, angioedema, night sweats, angioedema, hirsutism, skin burning sensation, generalized erythema

Hepatic

Frequency not reported: Liver disease, gallbladder disease, cholestatic jaundice, Budd-Chiari syndrome

Postmarketing reports: Cholelithiasis, cholecystitis

Hematologic

Frequency not reported: Hemolytic uremic syndrome

Postmarketing reports: Anemia

Immunologic

Postmarketing reports: Hypersensitivity reaction, anaphylactic/anaphylactoid reaction

Ocular

Frequency not reported: Corneal curvature change/steepening, contact lens intolerance, cataracts, retinal thrombosis

Postmarketing reports: Vision blurred, vision impaired, corneal thinning, fungal infection, transient blindness

Respiratory

Frequency not reported: Pulmonary embolism

Postmarketing reports: Asthma exacerbated, dyspnea

Musculoskeletal

Frequency not reported: Leg cramp, backache

Postmarketing reports: Myalgia, arthralgia, back pain

Metabolic

Common (1% to 10%): Weight fluctuation

Frequency not reported: Tolerance to carbohydrates reduced

Postmarketing reports: Appetite increased, appetite decreased, diabetes mellitus, hypoglycemia, hypocalcemia, triglycerides increased, blood glucose abnormal

Other

Common (1% to 10%): Cervical smear abnormal, weight gain, edema

Frequency not reported: Fatigue, porphyria, Vitamin B6 deficient

Postmarketing reports: Weight decreased, peripheral edema, malaise, chest pain

Renal

Frequency not reported: Renal function impaired

Postmarketing reports: Cystitis-like syndrome

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.

Source: Drugs.com Blisovi 24 Fe (www.drugs.com/mtm/blisovi-24-fe-birth-control.html).